ESMO and Immunotherapy by Ian Olver
ESMO 2017 Conference Review by Professor Ian Olver AM, for oncologynews.com.au. Almost 24,000 delegates gathered in Madrid…
Professor Ian Olver AM MD PhD is a Professorial Research Fellow at School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide. He is Immediate Past President of the Multinational Association of Supportive Care in Cancer. A renowned oncologist, cancer researcher and bioethicist, Ian has held senior positions in Australia and abroad. With research interests in anticancer drug studies, symptom control, bio-ethics and psycho-oncology, Ian is the author of more than 300 journal articles, 28 book chapters, has written 4 books and edited 4 others. He is a regular commentator on cancer issues in Australia and internationally.
ESMO 2017 Conference Review by Professor Ian Olver AM, for oncologynews.com.au. Almost 24,000 delegates gathered in Madrid…
Ian Olver, Director Sansom Institute for Health Research, University of South Australia for oncologynews.com.au Financial toxicity is…
COSA 2016: Work After Cancer session review by Professor Ian Olver AM, for oncologynews.com.au. A session…
Review of the MASCC Conference Adelaide 2016 by Ian Olver AM, MASCC President, for oncologynews.com.au. Over 1000…
By Ian Olver, University of South Australia. The Pharmaceutical Benefits Scheme (PBS) spends over A$9 billion…
Ian Olver, University of South Australia Absolute risk is the risk of developing a cancer…
By Ian Olver, Professor of Translational Cancer Research and Director of the Sansom Institute for Health Research, University…
Ian Olver, University of South Australia Keytruda® (pembrolizumab) is the latest drug to be registered…